These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20832239)

  • 1. [Schnitzler syndrome: A dramatic improvement with anakinra].
    Billey T; Beldjerd M; Popa L; Lassoued S
    Presse Med; 2010 Dec; 39(12):1338-9. PubMed ID: 20832239
    [No Abstract]   [Full Text] [Related]  

  • 2. [Schnitzler's syndrome: a case report and literature review of the response to treatment with anakinra].
    Benítez Gutiérrez L; Mellor Pita S; Tutor de Ureta P; Yebra Bango M
    Med Clin (Barc); 2013 May; 140(9):427-8. PubMed ID: 23177777
    [No Abstract]   [Full Text] [Related]  

  • 3. Remission of Schnitzler syndrome after treatment with anakinra.
    Frischmeyer-Guerrerio PA; Rachamalla R; Saini SS
    Ann Allergy Asthma Immunol; 2008 Jun; 100(6):617-9. PubMed ID: 18592830
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful anakinra therapy in 2 patients with Schnitzler syndrome.
    Szturz P; Adam Z; Hájek R; Mayer J
    Onkologie; 2011; 34(5):265-8. PubMed ID: 21577034
    [No Abstract]   [Full Text] [Related]  

  • 5. Dermal interleukin-1 expression and effective and long-lasting therapy with interleukin-1 receptor antagonist anakinra in Schnitzler syndrome.
    Volz T; Wölbing F; Fischer J; Braun M; Maggoschitz I; Schaller M; Berneburg M; Biedermann T
    Acta Derm Venereol; 2012 Jul; 92(4):393-4. PubMed ID: 22334118
    [No Abstract]   [Full Text] [Related]  

  • 6. Schnitzler Syndrome With Response to Anakinra Monotherapy: 7 Years of Follow-up.
    Hidalgo-García Y; García-Fernández E; Palacio-Aller L; Gonzalvo P
    Actas Dermosifiliogr; 2017 Dec; 108(10):956-958. PubMed ID: 28728792
    [No Abstract]   [Full Text] [Related]  

  • 7. Schnitzler syndrome: response to anakinra in two cases and a review of the literature.
    Schuster C; Kränke B; Aberer E; Arbab E; Sturm G; Aberer W
    Int J Dermatol; 2009 Nov; 48(11):1190-4. PubMed ID: 20064173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed development of the IgM paraprotein in Schnitzler's syndrome.
    Mulla E; Neame R
    Scand J Rheumatol; 2015; 44(6):521-2. PubMed ID: 26395927
    [No Abstract]   [Full Text] [Related]  

  • 9. IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission.
    Ryan JG; de Koning HD; Beck LA; Booty MG; Kastner DL; Simon A
    J Allergy Clin Immunol; 2008 Jan; 121(1):260-2. PubMed ID: 17936890
    [No Abstract]   [Full Text] [Related]  

  • 10. Anakinra: an effective treatment in the Schnitzler syndrome.
    Vandenhende MA; Bentaberry F; Morlat P; Bonnet F
    Joint Bone Spine; 2011 Dec; 78(6):636-7. PubMed ID: 21550281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schnitzler syndrome in a patient with a family history of monoclonal gammopathy.
    Wilmas K; Aria A; Torres-Cabala CA; Lu H; Duvic M
    Dermatol Online J; 2018 Jan; 24(1):. PubMed ID: 29469761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of Rheumatoid Arthritis in a Patient Treated with Anakinra for Schnitzler Syndrome: A Case Report.
    Margerin F; Gottenberg JE; Lipsker D
    J Rheumatol; 2016 Jul; 43(7):1447. PubMed ID: 27371651
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of Schnitzler's syndrome with anakinra.
    Gilson M; Abad S; Larroche C; Dhote R
    Clin Exp Rheumatol; 2007; 25(6):931. PubMed ID: 18173934
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of interleukin 1 receptor antagonist (anakinra) on a refractory case of Schnitzler's syndrome.
    Kluger N; Rivière S; Guillot B; Bessis D
    Acta Derm Venereol; 2008; 88(3):287-8. PubMed ID: 18480937
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anakinra treatment in Schnitzler syndrome -  results of the first retrospective multicenter study in six patients from the Czech Republic].
    Szturz P; Sedivá A; Zurek M; Adam Z; Stork J; Cermáková Z; Steyerová P; Vokáčová A; Hrbek J; Sýkora M; Spička I; Mechl Z; Mayer J
    Klin Onkol; 2014; 27(2):111-26. PubMed ID: 24739048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of 2-year treatment of Schnitzler syndrome (urticarial exanthema, monoclonal IgM gammopathy and osteolytic-osteosclerotic skeletal changes) using Anakinra (Kineret)].
    Adam Z; Krejcí M; Pour L; Hájek R
    Vnitr Lek; 2009 Dec; 55(12):1196-7. PubMed ID: 20070037
    [No Abstract]   [Full Text] [Related]  

  • 17. Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome.
    Sönnichsen A; Saulite I; Mangana J; Kerl K; Mehra T; Desislava I; Chang YT; Petrausch U; Schmid-Grendelmeier P; Hoetzenecker W; Cozzio A; Guenova E
    J Dermatolog Treat; 2016 Oct; 27(5):436-8. PubMed ID: 26864191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schnitzler's syndrome with biclonal gammopathy successfully treated with hydroxychloroquine and low dose steroids.
    Laganà B; Podestà E; Picchianti Diamanti A; Salerno G; Di Rosa R; D'Amelio R
    Clin Exp Rheumatol; 2008; 26(6):1161. PubMed ID: 19210890
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et al.
    Martinez-Taboada VM; Fontalba A; Blanco R; Fernández-Luna JL
    Arthritis Rheum; 2005 Jul; 52(7):2226-7. PubMed ID: 15986356
    [No Abstract]   [Full Text] [Related]  

  • 20. [Schnitzler syndrome is a diagnostic challenge].
    Duhn PH; Thomsen SF; Nordin H
    Ugeskr Laeger; 2015 Jul; 177(30):. PubMed ID: 26240044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.